Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.
Read Full NewsPreschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.
Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.
An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.
In patients with cancer receiving immune checkpoint inhibitor therapy, osteoarthritis is linked to the risk for inflammatory arthritis immune-related adverse events.
Researchers evaluate the impact of allogeneic stem cell transplantation in chronic myelomonocytic leukemia across BLAST and BLAST-Mol clinical risk models.
1.
Predicting adult mortality from oral cancer using a machine learning approach.
2.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
3.
Who Bears the Cost of "Forever Chemical" Cleanup?
4.
Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.
5.
How the metastasis of cancer is driven by cellular plasticity.
1.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
2.
The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition
3.
Emerging Models in Oncology for Specialists
4.
Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer
5.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
3.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
4.
Hands-on Workshop: Hematology
5.
A New Era in Managing Cancer-Associated Thrombosis
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge